Request for Proposal (RFP) to Tender for Purchasing a Vehicle to Support Surveillance Activities in the Democratic People's Rep
Request for Proposal (RFP) to Tender for Purchasing a Vehicle to Support Surveillance Activities in the Democratic People’s Republic of Korea
The International Vaccine Institute (IVI) (http://www.ivi.int) is a non-profit, international organization located in Seoul, Korea. IVI and the Academy of Medical Sciences (AMS) of the Democratic People’s Republic of Korea (DPRK) have been collaborating to improve the health of children in the Democratic People’s Republic of Korea (DPRK) since 2006.
IVI/AMS are currently collaborating to set up a surveillance system for acute encephalitis syndrome (AES) and diarrheal diseases caused by selected bacterial and viral pathogens (rotavirus, Vibrio cholerae, Campylobacter and Shigella species) through health care system capacity-building and training of DPRK scientists in collaboration with AMS and the Ministry of Public Health. To ensure successful implementation of the surveillance system in the DPRK, AMS requires a vehicle (Appendix 3) to bring collected specimens (blood and stool specimens from enrolled patients) from the hospitals and clinics in the rural areas to the reference laboratory in Pyongyang in a timely manner. To ensure transparency of the purchasing process, IVI is opening a tendering process with different companies in China to purchase a vehicle (SUV or jeep) which will be used for disease surveillance purposes within the DPRK.
The purpose of this Request for Proposal (RFP) is to advertise a tender for purchasing a vehicle which will be used for surveillance activities in the DPRK. A bidder will be selected by IVI through a competitive process to manage the procurement of a vehicle in China and shipment of the vehicle to the IVI’s collaborating institution (AMS) in the DPRK. Potential providers of this service are requested to describe how they intend to meet the requirements set out by IVI. A selection panel of IVI staff will analyze each proposal and ultimately select a final service provider.
The duration of the selection process is from May 01, 2013 to May 31, 2013, and follows IVI’s tendering regulations. Plans for money transfer will be developed in accordance with the timetable that will be discussed and agreed upon with the selected procurement agency.
d. Point of contact.
All applicants wishing to tender for this contract can fill out the application form enclosed as Appendices. Scientific and project-related questions can be directed to Dr. Florian Marks (email@example.com), and administrative and procedural questions can be directed to Ms. Hyejin Seo (firstname.lastname@example.org).
e. Structure of request for proposal
Information for this RFP is organized as follows:
- Section 2 contains the explanation of the selection process, indication of milestones, and definitions of conditions and criteria.
- Appendices include the application form and the specification of the vehicle.
2. Selection process
Transfer of assets to the procurement agency shall be realized by late April 2013. Current planning and timetable of the developed activities are shown below:
|Tender open date||03 May 2013|
|Request for further information open date||08 May 2013|
|Tender closing date||17 May 2013|
|Final selection||22 May 2013|
|Negotiation with successful applicant begins||24 May 2013|
|Contract signed||31 May 2013|
b. Procedure for responses
All interested bidders should complete the application form of the RFP (enclosed in the Appendices) and return it by email by May 17, 2013 to the following person:
Ms. Hyejin Seo
Translational Research Division
International Vaccine Institute
Tel: 82 2 881 1306
Fax: 82 2 872 1212
The following conditions apply to this selection process:
- A bidder can be excluded from the selection process without any consequences.
- Effort and time spent in replying to this RFP document by the bidder cannot be charged to IVI.
- IVI may decide to terminate the tender process at any stage, which will be notified through IVI website.
- All bids must be submitted in English.
- The bidding agency must be located in China.
In the course of the establishment of surveillance for acute encephalitis syndrome (AES) and diarrheal diseases, IVI will provide AMS with one vehicle. The bidding agency is required to purchase the vehicle, ship it to the country collaborators in the DPRK according to a pre-determined timeline and complete the achievement of project milestones, deliverables and documentation.